封面
市场调查报告书
商品编码
1425169

关节重组设备市场 - 2024 年至 2029 年预测

Joint Reconstruction Devices Market - Forecasts from 2024 to 2029

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计联合重组设备市场在预测期内将以 4.53% 的复合年增长率成长。

关节重建手术是一种旨在缓解关节炎和关节损伤的外科手术。在该手术中,受损的关节被移除并替代为由金属、塑胶或陶瓷材料製成的人工关节。人工关节旨在模仿健康关节的自然运动。全关节重建中使用的器械具有多种功能,包括更换或替代关节表面、提供初步固定以及作为关节关节重建过程中不可或缺的一部分。此外,辅助医疗设备也属于这一类。这包括特定的关节部位,例如髋关节的球和/或窝、股骨的两个髁、胫骨和/或膝盖骨的相应表面、股骨的转子槽、以及球和/或骨节。肩关节窝。包括要更换的设备。

市场驱动因素

  • 不断发展的技术

在全球范围内,多项创新技术改变了关节重建手术的格局。机器人、电脑导航、3D 列印植入、智慧感测器、穿戴式装置和扩增实境等创新正在对该领域产生重大影响。例如,电脑导航使用专用的软体和感测器来创建患者膝关节或髋关节的术前 3D 模型。先进的影像技术,包括 X 光、MRI 和新的 3D动态捕捉技术,在术前、术中和术后评估中发挥着至关重要的作用。

扩增实境技术是一项显着的进步,它使外科医生能够可视化患者膝盖的解剖结构,并透过在手术区域迭加影像来即时追踪手术进展。

「智慧」植入和穿戴式技术的整合改变了手术恢復方式,并促进了患者、外科医生和物理治疗师之间的积极合作。这些创新正在彻底改变关节关节重建手术的方法,提高整个过程的精确度、即时监控和患者参与度。

  • 老年人口增加

在全球范围内,关节重组设备市场受到人口变化的显着影响。 2016年,亚太地区约12.4%的人口年龄在60岁以上,但预计到2050年这一数字将增加到四分之一以上,即13亿人。在此背景下,医疗保健需求的上升值得关注。然而,在东亚和北亚(包括日本和韩国等人口老化严重的国家),预计到2050年将有超过三分之一的人口年龄在60岁以上,而且这种情况因地区而异。

在欧盟(EU),关节重组器械市场也受到人口老化的影响。欧盟27国的老年人口(此处定义为65岁以上人口)将大幅成长,从2019年初的9,050万增加到2050年的1.298亿。在此期间,欧盟27国75-84岁人口预计将增加56.1%,65-74岁人口将增加16.6%。

在关节重组器材市场和医疗保健的背景下,值得注意的是,在全球范围内,欠发达地区的老年人口增长速度快于已开发地区。因此,老年人将越来越集中在欠发达地区。我们强调医疗保健和相关技术(包括关节重组设备)日益重要。

市场挑战

  • 设备和流程高成本

与关节重组设备和手术相关的高成本对患者和医疗保健系统都构成了重大挑战。有几个因素造成了这种经济负担。首先,关节重组装置很复杂,通常由钛或钴铬等高级材料製成,製造成本昂贵。製造过程需要专门的设备和专业知识,进一步推高了成本。

此外,联合重组的综合性质涉及各种相关成本,而不仅仅是仪器本身。术后护理、外科医师费用、住院费用等都会造成整体经济负担。这些成本是联合重组过程的一个组成部分,也增加了挑战。

然而,随着新技术的发展和竞争性市场策略的出现,形势正在改变。这些进步也正在逐步改善联合重组领域的产品,也可能减少与共同重组相关的成本挑战。

依关节类型,关节重组器材市场分为膝关节、髋关节、肩关节、踝关节等。

在关节重组市场中,有许多按关节类型分类的需求。它主要是由技术进步所驱动的。膝关节重组由最尖端科技驱动,包括植入膝关节相关疾病植入的全膝关节置换术(TKR)和部分膝关节置换术(PKR) 。),我们提供量身定制的解决方案。髋关节重组透过全髋关节置换术术 (THR) 和使用股骨柄、髀臼杯和股骨头等先进植入进行髋关节表面置换术等手术来解决髋关节问题。

亚太地区(APAC)预计将占据关节重组设备市场的主要份额。

由于经济开拓和医疗保健支出的增加,预计亚太地区(APAC)将在关节重组设备市场中发挥重要作用。 2010年至2018年,亚太地区经济体的实质医疗支出占人均GDP的比例年平均成长6.4%。对这一增长做出贡献的着名国家包括中国、东帝汶和土库曼斯坦,这些国家的人均医疗支出相对于人均国内生产总值的比例迅速增长。医疗保健支出的这些趋势可能会改变医疗保健格局,特别是影响市场形势的发展。

公司产品

  • NewtonTM 平衡膝关节系统:NewtonTM 平衡膝关节系统采用即时、可量化的软组织资料,并作为类似 GPS 的工具执行针对患者的特定计划。使用牛顿通讯协定,外科医生可以获得全方位的综合软组织分析,并能够在开始切除之前预测术后稳定性。该系统透过简化的手术技术确保再现性并提供一致的结果。 NewtonTM 系统凭藉经过验证的 ±0.6mm 精度和准确度以及取得专利的无影像 GPS 主动追踪技术,提供可靠的性能。它以其实用效率而着称,其紧凑的设计适合门诊手术中心 (ASC),从而降低了资本成本和年度维护成本。
  • 膝关节关节重建产品:Zimmer Biomet 提供全面的膝关节关节重建产品,为外科医生的各种膝关节关节重建手术提供了多种选择。产品范围包括全膝关节置换术系统、部分膝关节置换术系统、双侧膝关节保留系统和膝关节重新置换系统。这些系统允许外科医生在每次手术中采取针对患者的具体方法。全附件系统优先考虑膝关节的自然运动,并根据个人解剖结构(包括初级附件系统)为膝关节重组提供广泛的植入选择。此外,Zimmer Biomet 透过膝关节重新置换系统提供固定、约束、软组织和骨缺损管理解决方案,以解决膝关节重新置换术中面临的挑战。
  • 髋关节植入(Stryker):在髋关节植入领域,我们为全髋关节置换术提供全面的产品系列,涵盖初次和重新置换产品组合。这些带有 SOMA 印记的产品系列经过精心设计,以确保最佳的贴合性和功能。 SOMA 的产品组合包括各种植入、设备和手术选择,特别强调置换术。这项承诺延伸到保持在最新进展的前沿,包括采用 Mako 全髋关节置换术术等创新方法。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章关节重组设备市场:依技术分类

  • 介绍
  • 关节重建
  • 截骨术
  • 关节镜
  • 重铺
  • 其他的

第六章关节重组器材市场:依关节类型

  • 介绍
  • 膝盖
  • 腰部
  • 肩膀
  • 其他的

第七章联合重组仪器市场:依最终使用者分类

  • 介绍
  • 医院
  • 诊所
  • 其他的

第八章联合重组设备市场:按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • Stryker
  • Drager
  • Exactech
  • Just Medical Devices(Tianjin)Co. Ltd.
  • Smith & Nephew
  • TTK Healthcare
  • JRI Orthopaedics
  • Zimmer Biomet
  • Meril Life
  • DSM Biomedical
简介目录
Product Code: KSI061616259

The joint reconstruction devices market is estimated to grow at a CAGR of 4.53% during the forecast period.

Joint replacement is a surgical intervention aimed at alleviating arthritis or damage in a joint. During this procedure, damaged joints are excised and substituted with a prosthesis crafted from metal, plastic, or ceramic materials. The prosthesis is designed to emulate the natural movement of a healthy joint. Devices used in joint replacement serve various functions, such as replacing or substituting the joint's articulating surface, providing primary fixation, and serving as intrinsic elements integral to the joint replacement process. Additionally, ancillary medical devices are also part of this category. This encompasses devices that replace specific joint parts, such as the ball and/or socket in the hip, the two condyles of the femur, and corresponding surfaces of the tibia and/or patella, or trochlear groove of the femur, and the ball and/or socket in the shoulder.

Market Drivers

  • Evolving technology

Globally, several transformative technologies have revolutionized the landscape of joint replacement surgeries. Innovations such as robotics, computer navigation, 3D printed implants, smart sensors, wearables, and augmented reality have significantly impacted the field. Technologies such as, computer navigation utilizes specialized software and sensors to create a pre-surgery 3D model of a patient's knee or hip joint. Advanced imaging techniques, including X-ray, MRI, and emerging 3D motion capture technology, play pivotal roles in pre-, intra, and post-operative assessments.

Augmented reality technology is a noteworthy advancement, allowing surgeons to visualize a patient's knee structures and track surgical progress in real-time by overlaying images onto the surgical field.

The integration of "smart" implants and wearable technology has transformed surgical recovery and fostered active collaboration between patients, surgeons, and physical therapists. These innovations mark a significant shift in the approach to joint replacement surgeries, enhancing precision, real-time monitoring, and patient engagement throughout the entire process.

  • Growing geriatric population

Globally, the joint reconstruction devices market is significantly impacted by the demographic shift. In 2016, approximately 12.4% of the population in the region of APAC was 60 years or older, but this is projected to increase to more than a quarter - or 1.3 billion- people by 2050. The growing healthcare needs in this context are notable. There are, however, variations across the region in East and North Asia (which includes countries with significant aging populations such as Japan and the Republic of Korea), over a third of the population is expected to be 60 years or older by 2050.

In the European Union, the joint reconstruction devices market is also influenced by the aging population. The population of older people (defined here as those aged 65 years or more) in the EU-27 will increase significantly, rising from 90.5 million at the start of 2019 to 129.8 million by 2050. During this period, the number of people in the EU-27 aged 75-84 years is projected to expand by 56.1%, while the number aged 65-74 years is projected to increase by 16.6%.

In the context of the joint reconstruction devices market and healthcare, it is noteworthy that globally, the older population in less developed regions is growing faster than in the more developed regions. Therefore, older persons will be increasingly concentrated in the less developed regions of the world. Emphasizing the growing importance of healthcare and associated technologies, including joint reconstruction devices.

Market Challenges

  • High cost of devices and procedures

The high cost associated with joint reconstruction devices and procedures poses a significant challenge for both patients and healthcare systems. Several factors contribute to this financial burden. Firstly, the intricacy of joint reconstruction devices, frequently crafted with high-grade materials such as titanium and cobalt chrome, leads to elevated production expenses. The manufacturing process necessitates specialized equipment and expertise, further driving up costs.

Additionally, the comprehensive nature of joint reconstruction involves not only the device itself but also various associated expenses. Post-operative care, surgeon fees, and hospital charges collectively contribute to the overall financial burden. These costs are integral components of the joint reconstruction process, adding to the challenges.

Nevertheless, the landscape is evolving with the advent of new technological developments and competitive marketing strategies. These advancements are gradually leading to improved offerings in the field of joint reconstruction, potentially mitigating some of the cost challenges associated with these procedures.

By joint type, the joint reconstruction devices market is divided into knee, hip, shoulder, ankle, and others

In the joint reconstruction market, categorization by joint type has multiple needs. It is primarily propelled by advancements in technology. Knee joint reconstruction, driven by cutting-edge technologies, offers tailored solutions for knee-related conditions, including total knee replacement (TKR) or partial knee replacement (PKR) with advanced femoral and tibial implants. Hip joint reconstruction tackles hip issues through procedures like total hip replacement (THR) and hip resurfacing, with advanced implants such as femoral stems, acetabular cups, and femoral heads.

APAC is anticipated to hold a significant share of the joint reconstruction devices market.

The Asia-Pacific (APAC) region is going to play a significant role in the joint reconstruction devices market, driven by economic development and increased healthcare expenditure. From 2010 to 2018, the APAC economies experienced an average annual growth of 6.4% in real health expenditure as a percentage of GDP per capita. Noteworthy contributors to this growth include China, Timor-Leste, and Turkmenistan, showcasing rapid increases in health expenditure per capita compared to GDP per capita. This trend in healthcare spending is set to change the healthcare landscape, particularly impacting advancements in the joint reconstruction devices market.

Market Developments

  • March 2023 - Stryker introduced the exclusive FDA-cleared hydrocarbon-bearing material choice for shoulder hemiarthroplasty. The inaugural procedure in the United States following the De Novo clearance utilized the Tornier Pyrocarbon Humeral Head, marking a significant milestone. Stryker's De Novo request, granted in late 2022, came after the successful completion of an Investigational Device Exemption (IDE) study in collaboration with the FDA.
  • March 2021 - Smith+Nephew, the global medical technology company, unveiled its newest Sports Medicine advancements for joint repair and arthroscopic enabling technologies at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago, IL. The cutting-edge technologies showcased will encompass the FAST-FIX FLEX Meniscal Repair System, INTELLIO Connected Tower, WEREWOLF FASTSEAL 6.0 Hemostasis Wand, REGENETEN Bioinductive Implant, and CAP-FIX◊ Suture Passer.
  • August 2021 - Zimmer Biomet and Canary Medical received FDA De Novo classification and approval to market the world's first and only Smart Knee Implant. The FDA granted authorization for the tibial extension component of Persona IQ®, a groundbreaking smart knee designed for total knee replacement surgery. Persona IQ® integrates Zimmer Biomet's established knee implant, Persona® The Personalized Knee®, with Canary Medical's exclusive implantable sensor technology called canturioTMte tibial extension. This technology measures and assesses various gait metrics, including range of motion, step count, and walking speed, marking a significant advancement in knee replacement surgery.

Company Products

  • NewtonTM Balanced Knee System - The NewtonTM Balanced Knee System employs real-time quantifiable soft tissue data, acting as a GPS-like tool for executing patient-specific plans. Utilizing the Newton protocol, surgeons can access comprehensive soft tissue analytics across the full range, predicting postoperative stability before initiating any resections. The system ensures reproducibility through a streamlined and simplified surgical technique, leading to consistent outcomes. With a proven ± .6mm accuracy and precision, and patented image-free GPS active tracking technology, the NewtonTM system offers reliable performance. Notably, its practical efficiency is highlighted by its compact, ambulatory surgery center (ASC)-friendly design, alleviating the burden of capital costs and annual maintenance fees.
  • Knee Replacement Products - Zimmer Biomet presents a comprehensive range of Knee Replacement Products, providing surgeons with versatile options for various knee replacement procedures. The offerings include Total Knee Systems, Partial Knee Systems, Bicruciate Preserving Arthroplasty Systems, and Revision Knee Systems. These empower surgeons to adopt a patient-specific approach for each procedure. The Total Knee Systems prioritize natural knee motion, offering extensive implant options for reconstructing the knee based on individual anatomy-covering Primary Knee Systems. Additionally, Zimmer Biomet addresses challenges encountered in revision knee arthroplasty, providing solutions for fixation, constraint, soft tissue, and bony defect management within Revision Knee Systems.
  • Hip Implants (Stryker) - In the realm of hip implants, they offer a comprehensive range for total hip arthroplasty, encompassing primary and revision portfolios. These portfolios are meticulously designed, bearing the SOMA imprint, ensuring optimal fit and function. Their offerings include a diverse array of implants, instrumentation, and surgical approach options, with a particular emphasis on novel muscle-sparing techniques for total hip arthroplasty. The commitment extends to staying at the forefront of the latest advancements, including the adoption of innovative approaches like Mako Total Hip Replacement.

Market Segmentation

By Technique

  • Joint Replacement
  • Osteotomy
  • Arthroscopy
  • Resurfacing
  • Others

By Joint Type

  • Knee
  • Hip
  • Shoulder
  • Ankle
  • Others

By End-user

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. JOINT RECONSTRUCTION DEVICES MARKET BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Joint Replacement
  • 5.3. Osteotomy
  • 5.4. Arthroscopy
  • 5.5. Resurfacing
  • 5.6. Others

6. JOINT RECONSTRUCTION DEVICES MARKET BY JOINT TYPE

  • 6.1. Introduction
  • 6.2. Knee
  • 6.3. Hip
  • 6.4. Shoulder
  • 6.5. Ankle
  • 6.6. Others

7. JOINT RECONSTRUCTION DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. JOINT RECONSTRUCTION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Stryker
  • 10.2. Drager
  • 10.3. Exactech
  • 10.4. Just Medical Devices (Tianjin) Co. Ltd.
  • 10.5. Smith & Nephew
  • 10.6. TTK Healthcare
  • 10.7. JRI Orthopaedics
  • 10.8. Zimmer Biomet
  • 10.9. Meril Life
  • 10.10. DSM Biomedical